| |
|
HIGH EFFICACY OF HCV THERAPY FOLLOWING UNIVERSAL DAA ACCESS IN AUSTRALIA
The REACH-C Cohort
|
| |
| |
Reported by Jules Levin
16th Annual International Symposium on Viral Hepatitis and Liver Disease’s Global Hepatitis Summit, 14–17 June 2018, Toronto, Canada
Jasmine Yee1, Gregory J Dore1,2, Josh Hanson1, 3, David Iser4, Mark Danta2, David Shaw5, Phillip Read6, Anne Balcomb7, Jeffrey Post8, Mark Montebello9, Patricia Collie10, Richard Hallinan11, Lucy Cooper12, Pip Marks1, Behzad Hajarizadeh1, Gail V Matthews1,2
1The Kirby Institute, UNSW Australia, Sydney, Australia 2St Vincent’s Hospital, Sydney, NSW, Australia 3Cairns Hospital, Cairns, Australia 4Scope Gastroenterology, Melbourne, Australia 5Royal Adelaide Hospital, Adelaide, Australia 6Kirketon Road Centre, Sydney, Australia 7Prince Street Medical, Orange, Australia 8The Albion Centre, Sydney, Australia 9The Langton Centre, Sydney, Australia 10Toormina Medical Centre, Coffs Harbour, Australia 11The Byrne Surgery, Sydney, Australia 12Matthew Talbot Hostel, Sydney, Australia
| |
| |
| |
|
|
|
